Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00028977 · ClinicalTrials.gov registry record · Phase 1
Herbal Therapy in Treating Women With Metastatic Breast Cancer
A Phase 1 study, sponsored by University of California, San Francisco.
- Completed
- Registry status
- Phase 1
- Development phase
- 21
- Enrollment target
NCT00028977 is a Phase 1 study that has completed, run by University of California, San Francisco. The registered enrollment target is 21 participants.
The verdict
NCT00028977, a Phase 1 study, has completed, sponsored by University of California, San Francisco.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 21 participants
- Enrollment target
Study Summary
RATIONALE: The Chinese herb Scutellaria barbata contains ingredients that may slow the growth of cancer cells and may be an effective treatment for metastatic breast cancer. PURPOSE: Phase I/II trial to study the effectiveness of Scutellaria barbata in treating women who have metastatic breast cancer.
Interventions
- DRUG herba scutellaria barbata
- OTHER herba scutellaria Barbatae (HSB)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21 participants |
| Start Date | 2001-08 |
| Est. Completion | 2006-04 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00028977
The ClinicalTrials.gov registry entry for NCT00028977 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 21 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of California, San Francisco, which has 1,713 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which herba scutellaria barbata is the first listed.
NCT00028977 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00028977 about?
NCT00028977 is a clinical study titled "Herbal Therapy in Treating Women With Metastatic Breast Cancer". RATIONALE: The Chinese herb Scutellaria barbata contains ingredients that may slow the growth of cancer cells and may be an effective treatment for metastatic breast cancer. PURPOSE: Phase I/II trial to study the effectiveness of Scutellaria barbata in treating women who have metastatic breast canc...
What is the current status of trial NCT00028977?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 21 participants. The study started on 2001-08. Estimated completion is 2006-04.
What interventions are being tested in trial NCT00028977?
The interventions under investigation include: herba scutellaria barbata (DRUG), herba scutellaria Barbatae (HSB) (OTHER).
Who is sponsoring clinical trial NCT00028977?
This trial is sponsored by University of California, San Francisco, which has 1,713 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.